Serum Sample Testing
Serum Sample Testing - Related Videos
01:24
Serum Studies: Renal Function Tests
0 Views •
2025
Renal function tests are crucial for assessing kidney health, monitoring disease progression, and evaluating the kidneys' efficiency in waste elimination, fluid balance, and electrolyte regulation. These tests offer critical insights into kidney function, even though routine measurements may appear normal until there is a significant decline in the glomerular filtration rate or GFR. Typically, signs of kidney impairment only become evident when the GFR falls to about 50% of its normal level.
08:43
Isolation of Endothelial Progenitor Cells from Healthy Volunteers and Their Migratory Potential Influenced by Serum Samples After Cardiac Surgery
0 Views •
Cited by 9 •
2017
Endothelial progenitor cells (EPCs) are crucially involved in the neovascularization of ischemic tissues. This method describes the isolation of human EPCs from peripheral blood, as well as the identification of their migratory potential against serum samples of cardiac surgical patients.
10:34
Measurement of Differentially Methylated INS DNA Species in Human Serum Samples as a Biomarker of Islet β Cell Death
0 Views •
Cited by 12 •
2016
Islet β cell death precedes development of type 1 diabetes, and detecting this process may allow for early therapeutic intervention. Here, we provide a detailed description of how to measure differentially methylated INS DNA species in human serum as a biomarker of β cell death.
05:59
Determining the Reactivity and Titre of Serum using a Haemagglutination Assay
0 Views •
Cited by 3 •
2010
Haemagglutination is a form of agglutination where antibodies bind to red blood cells. Red blood cells are both readily available and the results are readily observable using the naked eye. This video demonstrates the steps involved in a haemagglutination assay, interpreting the results and determining the titre.
06:44
Isolation of Small Noncoding RNAs from Human Serum
0 Views •
Cited by 13 •
2014
This protocol describes a method for extracting small RNAs from human serum. We have used this method to isolate microRNAs from cancer serum for use in DNA arrays and also singleplex quantitative PCR. The protocol utilizes phenol and guanidinium thiocyanate reagents with modifications to yield high quality RNA.
FAQs
Binding reactions provide the analytical basis for many serum measurements. In an ELISA or other immunoassay, the assay is configured to detect or quantify a selected antibody, antigen, cytokine, or soluble biomarker. This target-specific readout allows investigators to convert immune or infection-related molecular presence into data that can be compared across samples and study conditions.
The choice of target determines what biological question the result can address. Pathogen-specific antibodies can indicate prior exposure or an immune response, whereas antigens may reflect the presence of a pathogen-related target. Cytokines and other soluble biomarkers instead provide information about immune activity or disease-associated changes, so target selection should match the study objective.
Timing is a major interpretive variable in serum sample testing because measurements may reflect different stages of immune activity or infection. Controls help distinguish a meaningful assay signal from an unreliable result, while consistent timing and handling improve comparability among samples. These safeguards are especially important when evaluating vaccination, treatment, or changing disease-associated responses.
Reliable testing begins with careful collection, followed by allowing blood to clot and separating the liquid serum from cells and clotting proteins. The separated material must then be stored appropriately before analysis. Each stage can affect sample quality, so a consistent workflow is necessary to reduce technical variation and support comparisons between specimens.
Serum sample testing can support several immunology and infection research goals. Measurements may help identify prior pathogen exposure, characterize an ongoing immune response, examine disease-associated changes, or assess responses to vaccination and treatment. The same general approach therefore supports both infection-focused investigations and studies of how immune status changes after an intervention.
Results are most useful when interpreted alongside the target measured, sampling time, sample quality, and experimental controls. A detected antibody, antigen, cytokine, or other biomarker does not carry a single universal meaning; its significance depends on whether the study asks about exposure, infection-related activity, disease-associated change, vaccination, or treatment response. This context prevents overinterpretation.